ESC 365 - Estimating preventive treatment effect in individual patients from a lifetime perspective: the aspirin example

ESC Premium Access

Estimating preventive treatment effect in individual patients from a lifetime perspective: the aspirin example

Session: Improving cardiovascular disease prevention

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Doctor J. Dorresteijn (Utrecht, NL)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Jannick Dorresteijn

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 presentations

0 follower

4 more presentations in this session

State of the art in current cardiovascular disease prevention

Speaker: Professor J. Deanfield (London, GB)

The effects of statins on cardiovascular outcomes by smoking status. a systematic review and meta-analysis of randomized controlled trials.

Speaker: Associate Professor S. Ursoniu (RO)

Meta-analysis of non-invasive screening for coronary artery disease in asymptomatic patients with diabetes

Speaker: Doctor O. Clerc (Boston, US)

Future direction for research in cardiovascular disease prevention

Speaker: Professor C. Bairey Merz (Los Angeles, US)

Access the full session

Improving cardiovascular disease prevention

Speakers: Doctor J. Dorresteijn, Professor J. Deanfield, Associate Professor S. Ursoniu, Doctor O. Clerc, Professor C. Bairey Merz

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources